JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305536200 on June 13, 2003

J. Biol. Chem., Vol. 278, Issue 35, 32552-32560, August 29, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/35/32552    most recent
M305536200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, M. F.
Right arrow Articles by Goldberg, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, M. F., Jr.
Right arrow Articles by Goldberg, J. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Toll-like Receptor (TLR) 2 and TLR5, but Not TLR4, Are Required for Helicobacter pylori-induced NF-{kappa}B Activation and Chemokine Expression by Epithelial Cells*

Michael F. Smith, Jr. {ddagger} § , Anastasia Mitchell §, Guolian Li {ddagger}, Song Ding §, Ann Marie Fitzmaurice §, Kieran Ryan {ddagger}, Sheila Crowe {ddagger} and Joanna B. Goldberg §

From the University of Virginia Health System, Departments of Medicine, {ddagger}Digestive Health Center of Excellence and §Microbiology, Charlottesville, Virginia 22908-0708

Received for publication, May 27, 2003


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Infection with Helicobacter pylori, a Gram-negative, microaerophilic, flagellated bacteria that adheres to human gastric mucosa, is strongly associated with gastric ulcers and adenocarcinoma. The mechanisms through which gastric epithelial cells recognize this organism are unclear. In this study we evaluated the interactions between the Toll-like receptors (TLRs) and H. pylori-mediated NF-{kappa}B activation and the induction of chemokine mRNA expression. By reverse transcriptase-PCR we determined that MKN45 gastric epithelial cells express low but detectable amounts of TLR2, -4, and -5 but no MD-2. To determine which, if any, TLRs may play a role in the response of epithelial cells to H. pylori, HEK293 cells were cotransfected with the NF-{kappa}B-Luc reporter, CD14 and MD2 expression plasmids, and expression plasmids for TLR2, TLR4, or TLR5. Infection of the cultures with H. pylori (strain 26695) induced NF-{kappa}B activity in cells transfected with TLR2 and TLR5, but not TLR4. Consistent with the HEK293 experiments, H. pylori-induced NF-{kappa}B activation was decreased in MKN45 gastric epithelial cells by transfection of dominant-negative versions of TLR2 and TLR5 but not TLR4. Highly purified lipopolysaccharide from H. pylori strain 26695 activated NF-{kappa}B in HEK293 via TLR2 but not TLR4. Partially purified flagellin from H. pylori was also capable of inducing NF-{kappa}B activation in HEK cells transfected with TLR5. Additionally, chemokine gene expression was induced by H. pylori in HEK293 cells following stable transfection with TLR2 or TLR5 expression plasmids. These studies demonstrate that gastric epithelial cells recognize and respond to H. pylori infection at least in part via TLR2 and TLR5. Furthermore, the unique lipopolysaccharide of H. pylori is a TLR2, not a TLR4 agonist.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Helicobacter pylori is a spiral, microaerophilic, Gram-negative bacteria that colonizes gastric epithelial cells and the gastric mucosal layer in 25–50% of the population in developed countries and 70–90% in developing countries, for an estimated 2 billion people worldwide. Whereas most infected individuals are asymptomatic, H. pylori is a causative agent of peptic ulcer disease, gastric adenocarcinoma, and gastric mucosa-associated lymphoid tissue lymphoma. The specific clinical outcome is determined by the interplay of H. pylori virulence factors, host gastric mucosal factors, and the environment. However, the mechanisms by which bacterial and/or host factors cause disease remain unclear.

Gastric epithelial cells respond to infection with H. pylori by activating numerous signal transduction cascades. To date, the responses that have been best characterized are those which lead to expression and activation of c-fos and c-jun via mitogen-activated protein kinase pathways (1) and NF-{kappa}B (24). One result of the activation of these pathways is the production of large amounts of IL-81 by the gastric epithelial cells (2, 4, 5).

The mechanisms involved in the regulation of IL-8 production by H. pylori-infected gastric epithelial cells have been extensively studied. Aihara et al. (4) have demonstrated that AP-1 and NF-{kappa}B cooperate to regulate IL-8 gene expression in MKN45 cells. Mutation of both the AP-1 and NF-{kappa}B-binding sites in the IL-8 promoter resulted in a decrease in the response to H. pylori infection. Mutation of the AP-1 site alone resulted in a crippled promoter that was only partially responsive to H. pylori. In contrast, mutation of the NF-{kappa}B site resulted in a promoter that was completely nonresponsive to H. pylori infection demonstrating the critical importance of NF-{kappa}B in the response. Maeda et al. (6) further demonstrated that H. pylori-induced NF-{kappa}B activation in gastric epithelial cells involved I{kappa}B kinases, NIK, TRAF2, and TRAF6.

Cells of the innate immune system sense and respond to microbial products via the Toll-like receptor family. Toll-like receptors (TLR) are an evolutionarily conserved family of cell surface molecules that participate in innate immune recognition of pathogen-associated molecular patterns (7). Pathogen-associated molecular patterns are generally unique, chemically diverse products with conserved motifs that are produced by microorganisms. Pathogen-associated molecular patterns often have an essential role in the structure of bacteria and generally cannot be subtly modified as a result of mutation without adversely affecting microbial growth or pathogencity. Examples include LPS (specifically lipid A), peptidoglycan, lipoproteins, bacterial DNA, and bacterial flagella. At least 10 different TLRs have been identified. In some cases the bacterial ligand has also been identified. For example, TLR2 recognizes peptidoglycan (8) and bacterial lipoproteins (9). TLR4 recognizes LPS from most Gram-negative species (10), TLR5 reacts with flagellin (11), and TLR9 is a receptor for bacterial CpG DNA (12). The signaling events occurring downstream of the TLRs are rapidly being elucidated and appear to have many common features. In general, the cascade of events occurring following ligation of the different TLRs involves the activation of a common set of adapter proteins and protein kinases, the best characterized of which leads to the activation of NF-{kappa}B (reviewed in Refs. 13 and 14). All of the molecules identified by Maeda et al. (6) as being involved in H. pylori-induced NF-{kappa}B activation are also associated with responses downstream of the Toll-like receptors. The identity of the cell surface signaling molecule(s) responsible for the H. pylori-induced responses is still unclear.

One potential signaling receptor for H. pylori that has been examined in the literature is TLR4, originally identified as the signaling molecule responsible for cellular responses to LPS (10, 16). Recently, Kawahara et al. (17) demonstrated that H. pylori LPS stimulates TLR4 and induces mitogen oxidase 1 gene expression in guinea pig gastric pit cells. However, other investigators have provided evidence that H. pylori LPS does not stimulate human gastric epithelial cell lines (3, 4). To better clarify the role of Toll-like receptors in the responses of epithelial cells to H. pylori infection, we examined the activation of NF-{kappa}B in HEK293 cells transfected with specific TLR expression constructs and in the human gastric cancer cell line MKN45 expressing dominant negative versions of TLR2, TLR4, or TLR5. Our results indicated that live H. pylori induced NF-{kappa}B activation because of ligation of TLR2 and TLR5, but not TLR4. In addition, we have determined that LPS derived from H. pylori strain 26695 is a TLR2 agonist and demonstrate that the inability of MKN45 cells to respond to typical TLR4 agonists is because of a lack of the TLR4 accessory molecule MD2.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Reagents—LPS (Escherichia coli serotype 055:B5) was obtained from Sigma and H. pylori LPS was purified as described below. Prior to use, both LPS preparations were subjected to an additional purification procedure as described by Hirschfeld et al. (18). This procedure resulted in E. coli LPS that was free from contaminating endotoxin protein and is a specific TLR4 agonist. The synthetic lipopetide PAM3CSK4 was provided by Prof. G. Jung, Tübingen, Germany. Peptidoglycan purified from Staphyloccous aureus was purchased from Fluka.

Plasmid Constructs—Human TLR2, TLR4, and MD-2 expression plasmids were previously described (19). The TLR5 cDNA corresponding to the entire coding region was generated by reverse transcriptase (RT)-PCR using primers corresponding to the published sequences and cloned into pcDNA3.1Zeo (Invitrogen). Dominant-negative versions of TLR2, TLR4, and TLR5 were created by generating truncated cDNAs that resulted in deletion of the carboxyl-terminal portion of the molecule (TLR2 truncated at amino acid 670, TLR4 at 700, and TLR5 at 685). Sequences of all clones were confirmed by automated sequencing. The human CD14 expression vector, pRc/RSVCD14, was a gift of R. Ulevitch (Scripps Research Institute, La Jolla, CA); NF-{kappa}B-Luc was from Clontech. All plasmid DNAs were isolated by using endotoxin-free preparation kits from Qiagen (Valencia, CA).

Cell Culture and Transfection—HEK293 and AGS cells were from ATCC, MKN45 cells were purchased from the JCRB Cell Bank (Japan), and CHO-CD14 cells were a gift of D. Golenbock (University of Massachusetts). HEK293 cells were cultured in Dulbecco's modified Eagle's medium + 10% FBS (Hyclone), AGS cells in Ham's F-12 + 10% FBS and MKN45 in RPMI 1640 + 10% FBS. All cells were transfected in 24-well plates using LipofectAMINE (Invitrogen). Each transfection contained 500 ng of NF-{kappa}B-Luc (Clontech), 50 ng of TLR expression vector or pcDNA3.1Zeo, 50 ng of pEF6-MD2, 100 ng of pRc/RSVCD14, and 200 ng of pTK-Renilla (Promega) and 4 µl of LipofectAMINE. Transfections were performed in triplicate, cultured for 24 h, and then stimulated as indicated. Luciferase activities were determined using the dual luciferase kit from Promega and all activities were normalized to the activity of the cotransfected TK-Renilla plasmid.

RT-PCR of TLR mRNA—Total RNA was purified from cell lines using Trizol reagent (Invitrogen). Reverse transcription (RT) of 0.5 µg of total cellular RNA was performed in a final volume of 20 µl containing 5x first strand buffer (Invitrogen), 1 mM of each dNTP, 20 units of placental RNase inhibitor, 5 µM random hexamer, and 9 units of Moloney murine leukemia virus reverse transcriptase (Invitrogen). After incubation at 37 °C for 45 min, the samples were heated for 5 min at 92 °C to end the reaction and stored at –20 °C until PCR use. PCR was performed for 30 cycles under standard conditions using 2 µl of cDNA. Primers were generated such that the 5' and 3' primers were in separate exons. Sequences of primers used are shown in Table I.


View this table:
[in this window]
[in a new window]
 
TABLE I
RT-PCR primer sequences

 

Primary Culture of H. pylori—Gastric antrum specimens were taken from two patients recruited at the endoscopy unit at the University of Texas Medical Branch, Galveston, TX, according to the protocols outlined in a study approved by their Institutional Review Board. The specimens were placed in sterile normal saline and transported on ice. Homogenized tissues were cultured for <7 days at 37 °C on blood agar in an incubator containing 10% CO2. H. pylori growth was confirmed by Gram stain, and oxidase, catalase, and urease reactivity. The two isolates used in these studies were termed Hp98 and Hp99. H. pylori strain LC11 was a gift from P. Sherman (Hospital for Sick Children, Toronto, Ontario, Canada) (5) and strain 26695 was from K. Eaton (Ohio State University, Columbus, OH).

H. pylori in Vitro Infection—All H. pylori strains were grown for 24 h on Remel sheep blood agar plates, in 10% CO2 at 37 °C. One plate of bacteria was harvested with a sterile cotton swab and resuspended in 1 ml of Brucella broth. The bacteria were pelleted in a microcentrifuge at 6000 rpm for 5 min and resuspended in 1 ml of Brucella broth. This wash procedure was repeated and the bacteria were thoroughly resuspended in 1 ml of Brucella broth. Thirty microliters of the H. pylori suspension were plated to verify the multiplicity of infection. Twenty-four hours after transfection, the media was removed from the HEK293 or MKN45 cells and was replaced with fresh Dulbecco's modified Eagle's medium with 10% FBS or RPMI with 10% FBS, respectively. H. pylori then were added to the eukaryotic cells at a multiplicity of infection of 200–300:1. The infection proceeded for 24 h at 37 °C and 10% CO2.

H. pylori LPS Extraction—H. pylori strain 26695 was grown on Remel sheep blood agar at 37 °C, in 10% CO2 for 72 h. The confluent bacterial growth from 900 plates was harvested from each plate with 1 ml of sterile phosphate-buffered saline. The biomass was pooled and washed twice with phosphate-buffered saline and subsequently freezedried, yielding ~5 g of dried biomass. The LPS was extracted using the hot phenol-water protocol of Moran et al. (20), followed by protease treatment. All equipment was treated with EtoxaClean to remove all endotoxin contaminants. Briefly, the biomass was resuspended in endotoxin-free water at a concentration of 1 g/ml and homogenized for 10 min at high speed in a Sorvall Omni mixer. An equal volume of liquified phenol was added to the bacterial suspension and heated at 65 °C for 1 h. The solution was then blended for regular 2-min intervals, for a total of 10 min, at high speed in a Sorvall Omni mixer, and then cooled on ice. The mixture was centrifuged at 5,000 x g at 4 °C for 15 min, and the aqueous layer was collected. An equal volume of endotoxin-free water was added to the remaining phenol layer, mixed, and the centrifugation and collection steps were repeated for a total of 3 aqueous layer collections. The aqueous phases were combined and dialyzed against 6 liters of endotoxin-free water for 72 h to remove all residual phenol and freeze-dried. The crude LPS was resuspended at 10 mg/ml in 0.1 M Tris-HCl buffer, pH 7.5, containing 1 mg/10 ml of DNase II and RNase A, and 0.1 mg/10 ml of proteinase K. The suspension was incubated at 37 °C for 16 h, and then at 65 °C for an additional 16 h. The enzyme-treated LPS was dialyzed again against 6 liters of endotoxin-free water over 72 h to remove degraded compounds. The resulting solution was freeze-dried for 48 h. Prior to use, LPS was subjected to an additional purification procedure as described by Hirschfeld et al. (18).

H. pylori Flagellin Preparation—H. pylori 26695 were grown on Remel sheep blood agar at 37 °C, in 10% CO2 for 72 h. The bacteria were harvested from each plate with 1 ml of sterile Brucella broth. Bacteria from 100 plates were pooled and were blended for 1 min at high speed in a Sorvall Omni mixer. Bacterial cells were removed from solution by centrifugation at 15,000 x g at 4 °C for 25 min. The supernatant containing the sheared H. pylori flagella was ultracentrifuged at 100,000 x g at 4 °C for 90 min. The supernatant was discarded and the flagellar pellet was resuspended in 1 ml of sterile phosphate-buffered saline. Total protein concentration of the flagellin preparation was determined by the Bradford method using Pierce BCA reagents and protocol.

Quantitative RT-PCR—Total RNA was purified using the Trizol reagent (Invitrogen). RT of 0.5 µg of total cellular RNA was performed in a final volume of 20 µl containing 5x first strand buffer (Invitrogen), 1 mM of each dNTP, 20 units of placental RNase inhibitor, 5 µM random hexamer, and 9 units of Moloney murine leukemia virus reverse transcriptase (Invitrogen). After incubation at 37 °C for 45 min, the samples were heated for 5 min at 92 °C to end the reaction and stored at –20 °C until PCR use. Two µl of cDNA was subjected to real-time quantitative PCR using the Opticon system (MJ Research) with SYBR Green I (Molecular Probes, Eugene OR) as a fluorescent reporter. Chemokine and hypoxanthine phosphoribosyltransferase cDNAs were amplified in separate reactions. Threshold cycle number, of duplicate reactions, was determined using the Opticon software and levels of chemokine mRNA expression were normalized to hypoxanthine phsophoribosyltransferase levels using the formula 2(RtEt), where Rt is the mean threshold cycle for the reference gene (hypoxanthine phosphoribosyltransferase) and Et is the mean threshold cycle for the experimental gene. Data are thus expressed as arbitrary units. Primer sequences are provided in Table I.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Toll-like Receptor mRNA Expression in AGS and MKN45 Gastric Epithelial Cell Lines—To determine which TLRs are expressed on gastric epithelial cells and thus may participate in the response to H. pylori we examined TLR2, TLR4, TLR5, and MD2 mRNA expression by RT-PCR. As shown in Fig. 1, AGS and MKN45 cells express mRNA for TLR4 and TLR5. TLR2 mRNA expression was not detectable in AGS cells, but could be readily detectable in MKN45 cells. The expression of MD2, a critical co-factor for the ability of TLR4 to recognize LPS, was not detected in AGS or MKN45 cells. Thus, although both gastric epithelial cell lines examined express the mRNA for the LPS signaling molecule TLR4, the lack of MD2 expression suggests that these cells may lack the ability to signal via TLR4.



View larger version (83K):
[in this window]
[in a new window]
 
FIG. 1.
Expression of Toll-like receptor mRNAs in AGS, MKN45, and HEK293 cells. The expression of TLR2, TLR4, TLR5, and MD2 mRNA in AGS, MKN45, HEK293, and peripheral blood mononuclear cells (PBMC) was analyzed by RT-PCR. cDNA from a single RT reaction was used as a template for individual PCR with specific primers for the indicated genes. Specific amplicons were visualized by agarose gel and staining with EtBr. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

 

We next determined the capacity of MKN45 cells to activate NF-{kappa}B in response to TLR ligands. MKN45 cells were transiently transfected with a NF-{kappa}B/luciferase reporter plasmid and abilities of the synthetic lipopetide PAM3CSK4 (a TLR2 agonist), highly purified E. coli LPS (a TLR4 agonist), or live H. pylori, to induce luciferase expression were determined. As shown in the transfection experiment in Fig. 2A, PAM3CSK4 and H. pylori were capable of activating NF-{kappa}B in MKN45 cells, whereas E. coli LPS could not. Similar results were seen using another TLR2 agonist, peptidoglycan (data not shown). Thus, MKN45 cells are in fact responsive to at least some TLR agonists.



View larger version (23K):
[in this window]
[in a new window]
 
FIG. 2.
NF-{kappa}B activation in MKN45 cells. A, MKN45 cells were transiently transfected with NF-{kappa}B-Luc and pRLTK and stimulated with 100 ng/ml of PAM3CSK4, 1 µg/ml E. coli LPS, or live H. pylori for 18 h. Luciferase activities were normalized to the activity of the cotransfected Renilla luciferase. B, MKN45 cells were transiently transfected with NF-{kappa}B-Luc, pRLTK, and either empty vector or pEF6-MD2. Cultures were stimulated with 1 µg/ml LPS for 18 h prior to assay for luciferase activity. Data are mean ± S.D. of triplicate transfections.

 

To determine whether the inability of MKN45 cells to respond to E. coli LPS was because of the lack of MD2 expression, the experiment in Fig. 2B was performed. MKN45 cells were cotransfected with expression plasmids for CD14 and MD2 (or empty vector control) along with the NF-{kappa}B reporter. E. coli LPS was capable of activating NF-{kappa}B but only when the MD2 expression plasmid was cotransfected. These results indicate that MKN45 cells do in fact express a functional TLR4 protein but because of the lack of MD2 expression they are incapable of responding to LPS. This then provides a potential explanation for the lack of effect of H. pylori LPS on MKN45 cells observed by Aihara et al. (4).

H. pylori Activates NF-{kappa}B in HEK293 Cells via TLR2 and TLR5—To determine which, if any, TLRs may play a role in the response of epithelial cells to H. pylori, we chose to examine the H. pylori-induced NF-{kappa}B response in HEK293 cells transfected with TLR2, TLR4, or TLR5. In the representative transfection experiment (of 3 total) shown in Fig. 3, HEK293 cells were cotransfected with the NF-{kappa}B-Luc reporter, CD14 and MD2 expression plasmids, and either empty pcDNA3.1 vector or expression plasmids for TLR2, TLR4, or TLR5. Cultures were stimulated with either purified TLR ligands (Pam3CSK4 for TLR2 or E. coli LPS for TLR4) or live H. pylori for 24 h and assayed for luciferase activity. The results indicated that cells transfected with TLR2 or TLR5 expression plasmids, but not TLR4, were capable of activating NF-{kappa}B in response to H. pylori. The transfected TLR4 was indeed functional as demonstrated by the ability of the cells to activate NF-{kappa}B in response to E. coli LPS.



View larger version (52K):
[in this window]
[in a new window]
 
FIG. 3.
H. pylori activates NF-{kappa}B via TLR2 and TLR5 in HEK293 cells. A, HEK293 cells were transiently transfected with NF-{kappa}B-Luc, pEF6-MD2, pRc/RSV-CD14, and either pcDNA3.1 or expression plasmids for TLR2, TLR4, or TLR5. Twenty-four hours after transfection, cultures were stimulated with 1 µg/ml E. coli LPS, 100 ng/ml PAM3CSK4, or live H. pylori. Luciferase activities were determined 18 h later and normalized to cotransfected pRLTK activity. Results are mean ± S.D. of triplicate transfections and is a representative experiment of three performed. nd, not determined. B, HEK293 cells were transiently transfected with NF-{kappa}B-Luc and pcDNA3.1, TLR2, or TLR4 as in A. Cultures were infected for 24 h with the indicated strain of H. pylori prior to assay for luciferase expression as above. Hatched bars represent cultures treated with either 100 ng/ml PAM3CSK4 (for TLR2) or 1 µg/ml E. coli LPS (for TLR4).

 

This surprising result prompted us to examine other H. pylori strains to determine whether the lack of TLR4 response observed for strain 26695 was a specific attribute of that particular laboratory-adapted strain. To address this question, we performed infections of HEK293 cells transfected with either TLR2 or TLR4 expression plasmids using three additional strains of H. pylori: LC11 and two primary clinical isolates: HP98, and HP99. As shown in Fig. 3B, cotransfection of TLR2 but not TLR4 was able to confer the ability to activate NF-{kappa}Bin response to infection with all three strains. These results additionally suggested that although H. pylori is a Gram-negative bacterium, it has either developed a mechanism to avoid detection via TLR4 or its unique LPS is not recognized by TLR4. Thus in HEK293 cells TLR2 and TLR5 can confer responsiveness to live H. pylori infection.

Role of Toll-like Receptors on Gastric Epithelial Cells in Response to H. pylori Infection—The studies described above indicated that in a reconstitution experiment, TLRs can participate in the response of epithelial cells to H. pylori. To determine the role of endogenously expressed TLRs in the response of gastric epithelial cells to H. pylori we chose to inhibit TLR function through the expression of dominant-negative TLR constructs. The TLRs function as dimers and expression of a mutated receptor, deleted of the carboxyl-terminal cytoplasmic domain has been demonstrated to act as a repressor of TLR signaling. MKN45 cells were cotransfected with NF-{kappa}B-Luc and either empty expression vector (pcDNA3.1) or expression plasmids encoding truncated versions of TLR2, TLR4, or TLR5. Cultures were stimulated by addition of live H. pylori for 24 h. The results of a representative transfection experiment (of three) are shown in Fig. 4. Consistent with the results from the HEK293 experiments, cotransfection with dominant-negative TLR2 and TLR5, but not TLR4, resulted in an inhibition of the response of MKN45 cells to H. pylori infection. Thus, in a gastric epithelial cell line, as in the HEK293 cells, H. pylori activated NF-{kappa}B primarily via TLR2 and TLR5 but not TLR4.



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 4.
H. pylori 26695 activates NF-{kappa}B via TLR2 and TLR5 in MKN45 gastric epithelial cells. MKN45 cells were transiently transfected with NF-{kappa}B-Luc, pRLTK, and either empty pcDNA3.1 vector or expression vectors for dominant-negative TLR2, TLR4, or TLR5. Cultures were treated as described in the legend to Fig. 3. nd, not determined. Results are mean ± S.D. of triplicate transfections and is a representative experiment of three performed. *, p < 0.05 compared with vector control by two-way analysis of variance.

 

LPS from H. pylori Is a TLR2 Agonist—The data shown in Figs. 3 and 4 indicated that TLR2 and TLR5, but not TLR4, participated in the response to live H. pylori infection. This was a surprising result because H. pylori is a Gram-negative bacterium. However, this bacterium can produce two types of lipid A, a major tetraacyl and a minor hexaacyl variety with exceptionally long fatty acid chains (20). The structure of the tetraacyl lipid A moiety is clearly distinct from that found in Enterobacteriaceae and more closely resembles that found in Porphyromonas gingivalis, which is a TLR2 agonist (20, 21). Notably, LPS from H. pylori has been shown to be less toxic than that of E. coli. To determine whether the H. pylori LPS is a TLR2 or a TLR4 agonist, we purified the LPS from strain 26695 according to the procedure of Moran et al. (20) with the addition of three more extractions as described by Hirschfeld et al. (18) to yield highly purified, protein-free LPS. As shown in Fig. 5, HEK293 cells transfected with an NF-{kappa}B/luciferase reporter and TLR2, but not TLR4, responded to H. pylori 26695 LPS indicating that the LPS derived from this organism is predominantly a TLR2 agonist. This result is in contrast to studies published by Kawahara et al. (17, 22) that indicated that H. pylori LPS activated guinea pig gastric pit cells via TLR4. In addition, studies by Sakagami et al. (23) suggested that the LPS of Helicobacter felis was an important participant in Helicobacter-mediated gastritis because no atrophy was seen in the infected C3H/HeJ non-LPS responder animals, which have a non-functional TLR4. At present the reasons for this discrepancy are unclear but our hypothesis is that the lipid A composition of H. pylori LPS may differ between bacterial strains and/or may be affected by differing culture conditions. Studies to answer this question are underway. Alternatively, species differences in the recognition of lipid A variants has been reported and could potentially account for the discrepancies between our in vitro studies with human TLRs and the in vivo mouse data (24). Regardless, these findings clearly indicated that the LPS from H. pylori strain 26695 when cultured under our routine conditions was a TLR2 and not a TLR4 agonist, thus providing an explanation for the results shown in Fig. 4.



View larger version (11K):
[in this window]
[in a new window]
 
FIG. 5.
LPS from H. pylori 26695 is a TLR2 agonist. HEK293 cells were transfected with NF-{kappa}B-Luc, pRLTK, pEF6MD2, pRc/RSV-CD14 and either pcDNA3-TLR2 or pcDNA3-TLR4. Cultures were stimulated for 18 h with 5 µg/ml H. pylori LPS, 1 µg/ml E. coli LPS, or 100 ng/ml PAM3CSK4 prior to assay for luciferase activity. Data are mean ± S.D. of triplicate transfections.

 

CD14 Enhances the Response of Gastric Epithelial Cells to H. pylori—The gastric epithelial cells examined in this study did not express detectable levels of CD14 (data not shown). However, because CD14 can be found in inflammatory exudates and serum as a soluble protein that can enhance the response of cells to LPS (25, 26), we wanted to examine the potential role of this pattern recognition molecule in the response of gastric epithelial cells to H. pylori infection. MKN45 cells were transiently transfected with NF-{kappa}B-Luc and either empty pRc/RSV vector or pRc/RSV-CD14 and stimulated by infection with H. pylori as above. As shown in Fig. 6A, forced expression of CD14 in MKN45 cells was able to significantly enhance the activation of NF-{kappa}B following infection. To determine whether soluble CD14 could likewise enhance the response of gastric epithelial cells to H. pylori infection, we used culture supernatants from CHO cells stably transfected with CD14 (a gift of D. Golenbock, University of Massachusetts) as a source of soluble CD14. In the experiment shown in Fig. 6B, MKN45 cells were transfected with the NF-{kappa}B-Luc reporter plasmid and infected with H. pylori in the presence of a 10% volume of media from either CHO or CHO-CD14 cells. In agreement with the previous experiment, soluble CD14 was also capable of enhancing the response of MKN45 cells to H. pylori.



View larger version (20K):
[in this window]
[in a new window]
 
FIG. 6.
CD14 enhances the responses of MKN45 cells to H. pylori. A, MKN45 cells were transiently transfected with NF-{kappa}B-Luc and either empty vector control or pRc/RSV-CD14. Cultures were infected with H. pylori 26695 and luciferase activities were determined as above. B, MKN45 cells, transiently transfected with NF-{kappa}B-Luc, were infected with H. pylori 26695 in the presence or absence of conditioned media from CHO-CD14 cells as a source of soluble CD14. C, MKN45 cells were transiently transfected as in A and cultures were stimulated for 18 h with 100 ng/ml PAM3CSK4 or 10 µg/ml H. pylori LPS prior to assay for luciferase activity. All transfections were performed in triplicate and data represent mean ± S.D.

 

To further characterize the effect of CD14 on the gastric epithelial response to H. pylori, we examined the role of CD14 in enhancing the response of MKN45 cells to LPS purified from H. pylori 26695. In the experiment shown in Fig. 6C, MKN45 cells were transfected with the NF-{kappa}B-Luc reporter and either empty vector or pRc/RSV-CD14. Following transfection, cells were stimulated with either PAM3CSK4 or H. pylori LPS. In the absence of CD14, H. pylori LPS was incapable of inducing NF-{kappa}B activity, however, expression of CD14 rendered the cells responsive to H. pylori LPS. Consistent with previous reports, the synthetic bacterial lipopeptide PAM3CSK4 was capable of inducing responses in the absence of CD14 but the response was enhanced by CD14 expression (27).

Purified H. pylori Flagellin Activates NF-{kappa}B via TLR5— H. pylori is a flagellated bacterium that likely explains its ability to stimulate HEK293 and MKN45 cells via TLR5. To confirm that the responses observed above are in fact because of the interaction of H. pylori flagellin with TLR5, we generated a partially purified flagellin preparation from H. pylori cultures and assessed the ability of this material to activate NF-{kappa}B in both HEK293 and MKN45 cells. As shown in Fig. 7A, stimulation of HEK293 cells with this flagellin preparation resulted in NF-{kappa}B activation in cells transfected with either TLR5 or TLR2. Treatment of the flagellin preparation with polymyxin B partially inhibited the response of HEK-TLR2 cells but had no effect on HEK cells transfected with TLR5. Likewise, as shown in Fig. 7B, transfection of MKN45 cells with a dominant negative TLR5 construct partially inhibited the response of the cells to the flagellin preparation. These results therefore indicated that H. pylori is capable of activating gastric epithelial cells as a consequence of flagella expression and as predicted this response is mediated via TLR5.



View larger version (23K):
[in this window]
[in a new window]
 
FIG. 7.
H. pylori flagellin is a TLR5 agonist. A, HEK293 cells were transiently transfected with NF-{kappa}B-Luc and pcDNA3.1, TLR2, or TLR5 as described in the legend to Fig. 3. Cultures were stimulated for 18 h with 10 µg/ml flagellin (Fla) or flagellin plus 10 µg/ml polymyxin B (PXB) prior to assay for luciferase activity. B, MKN45 cells were transfected with NF-{kappa}B-Luc and dominant-negative TLR5 or vector control. Cultures were stimulated for 18 h with 10 µg/ml flagellin. Data are mean ± S.D. of triplicate transfections.

 

H. pylori Induces Chemokine Gene Expression via TLR2 and TLR5—The studies described above were limited to the analysis of NF-{kappa}B activation in response to H. pylori infection. To determine whether Toll-like receptor expression is a prerequisite for the other biological responses induced via H. pylori we chose to examine chemokine gene expression in HEK293 cells that were stably transfected with TLR2 and TLR5 expression plasmids. Following infection for 6 h with H. pylori 26695, mRNA expression for IL-8, MIP-3{alpha}, and GRO{alpha} was analyzed by quantitative RT-PCR. As shown in Fig. 8, in the absence of TLR expression, H. pylori had a minimal effect on chemokine gene expression: the expression of each gene was induced between 3- and 8-fold. However, stable expression of TLR2 resulted in extremely enhanced expression of all three chemokine genes. Likewise expression of TLR5 also enhanced the induction of chemokine gene expression in response to H. pylori infection although the effect was less dramatic than that observed for TLR2. The differences in the abilities of TLR2 and TLR5 to enhance chemokine gene expression may be reflective of differing concentrations/bioavaliabilities of the respective ligands and/or different expression levels of TLR2 or TLR5 on the surface of the HEK cell lines. Whether the low levels of chemokine expression induced in response to infection of the wild-type cell line are because of the low amount of TLR5 levels detected in HEK293 cells or are because of other TLR-independent pathways remains to be determined.



View larger version (15K):
[in this window]
[in a new window]
 
FIG. 8.
H. pylori-induced chemokine expression is dependent upon TLR expression. HEK293, HEK-TLR2, and HEK-TLR5 were infected with H. pylori 26695 for 6 h prior to isolation of total mRNA. Expression of mRNAs for IL-8, MIP-3{alpha}, and GRO-{alpha} were determined by quantitative RT-PCR as described under "Experimental Procedures."

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In this study we have explored the role of Toll-like receptors in the response of epithelial cells to H. pylori infection. Previous studies in mice and guinea pigs have provided evidence that TLR4 may be an important contributing factor to the inflammatory response induced by H. pylori (3, 17, 22), however, the roles of other Toll-like receptors in the interaction of gastric epithelial cells with H. pylori have not been previously characterized. The data presented here demonstrate that infection of epithelial cells in vitro with H. pylori induces NF-{kappa}B cellular responses via TLR2 and TLR5, but surprisingly not TLR4. Furthermore, our data using highly purified LPS from H. pylori strain 26695 indicated that similar to LPS from P. gingivalis (21) this LPS was a TLR2 agonist.

H. pylori has been demonstrated to require flagella for efficient colonization and maintenance of infection in the gastric epithelium (28, 29). An indication that H. pylori flagellin may play a significant role in disease progression was suggested by a report that demonstrated restriction fragment length polymorphisms in flagellin genes. Significant differences in IL-8 production were noted between groups with different restriction-fragment length polymorphisms and highly motile strains were associated with increased levels of IL-8 production (30). The response of cells of the innate immune system to flagellated bacteria was demonstrated by Hyashi et al. (11) to be mediated via interactions between bacterial flagellin and TLR5. The data presented herein indicate that gastric epithelial cells express TLR5 and respond to H. pylori at least in part through activation of this receptor.

Whereas the TLR5-mediated response to H. pylori was somewhat predictable, the non-responsiveness of cells via TLR4 was surprising. While these studies were in progress, Kawahara et al. (17) demonstrated that H. pylori LPS acted via TLR4 to stimulate production from guinea pig gastric pit cells. Guinea pig gastric pit cells were demonstrated to be deficient in expression of TLR2 and thus all LPS-dependent responses were presumed to occur via TLR4. Interestingly, in these studies only three of the six LPS preparations tested were capable of activating Mox1 and inducing p67phox expression. Previously, Moran et al. (20) had demonstrated that the lipid A component of H. pylori LPS was a mixture of two forms: a predominant tetraacyl variety and a minor hexaacyl form. One important implication of that study is that different strains of H. pylori, or perhaps the same strain cultured under different conditions, may produce lipopolysaccharides containing varying amounts of either hexaacyl or tetraacyl lipid A. Of particular importance to the results presented here and the studies of Kawahara et al. (17, 22), is that the tetraacyl lipid A structure of H. pylori is reminiscent of the lipid A structure of P. gingivalis, which has been demonstrated to be a TLR2 agonist (21). Additionally, consistent with this thought is the demonstration that LPS from H. pylori and P. gingivalis bind poorly to LPS-binding protein and are therefore transferred less efficiently to CD14 (31). Thus, we hypothesize that the lack of responses observed for the three LPS preparations in the Kawahara study may reflect differences in the lipid A structures produced by the different strains of bacteria. Studies are in progress to define the lipid A structure of the H. pylori LPS used in our studies and to determine whether variations in culture conditions and/or strain of H. pylori can influence the relative abilities to activate cells via TLR2 or TLR4.

The finding that H. pylori induces responses in epithelial cells primarily via TLR2 and TLR5, and not TLR4, may provide some insight into the reasons for the relatively low pathogenicity of this organism and the trend toward the development of a chronic, low-level inflammation in the gastric mucosa. Gene expression studies following stimulation of immune cells with TLR2 or TLR4 agonists have been performed by numerous labs (21, 32). The noteworthy finding of these reports is that stimulation of cells via TLR4 results in the expression of the same sets of proinflammatory mediators as does TLR2 with the exception that TLR4 stimulation also results in the production of interferon-{beta} and concomitant downstream expression of interferon-inducible genes, including IP-10, MCP-5, and iNOS (32). Thus, the end result of TLR4-dependent responses is a more highly inflammatory phenotype in response to infection. Because H. pylori may be more inclined to activate cells via TLR2, the resulting inflammatory response will be more muted perhaps allowing this organism to establish a chronic foothold in the gastric epithelium. The gene expression profiles induced in response to TLR5-dependent agonists, i.e. flagellin, have not as yet been investigated. However, given the known similarities in downstream signaling mechanisms for TLR2 and TLR5, i.e. both have an absolute requirement for MyD88 (11, 33), it is likely that stimulation via either receptor independently will result in similar gene expression patterns and a moderate inflammatory response. The data presented herein indicated that H. pylori induced IL-8, MIP-3{alpha}, and GRO{alpha} in both HEK293-TLR2 and HEK293-TLR5 cells. Although in our studies the absolute levels of chemokine gene expression were different between the two cell types, perhaps as a result of different ligand and/or receptor concentrations.

Finally, it is important to point out that our studies do not rule out a role for other H. pylori virulence factors in the responses of epithelial cells to infection. Clearly, numerous studies have pointed to the important role that the cag pathogenicity island plays in the development of gastritis and in responses induced in gastric epithelial cells. The CagA protein in particular appears to play a critical role in the regulation of gene expression in gastric epithelial cells (34). Although, the mechanism through which CagA effects cellular responses is still unclear, a report demonstrating the interaction of CagA with SHP2 is particularly intriguing (35). We would predict that stimulation of gastric epithelial cells with purified TLR2 and TLR5 agonists will result in the regulation of a subset of genes that are also regulated in response to H. pylori infection. It is highly likely that the response induced by H. pylori will be both qualitatively and quantitatively different from that which we observe with the purified TLR agonists, possibly due in part to the presence of cag pathogenicity island by H. pylori. Interestingly, Guillemin et al. (34) noted that the genes whose expressions were least effected by the Cag phenotype were those involved in the immune response thus suggesting that Toll-like receptor activation may be directly responsible for the regulation of that subset. Consistent with the studies reported here, a recent report by Bäckhed et al. (15) demonstrated that regulation of gastric mucosal responses to H. pylori is TLR4-independent but cag pathogenicity island-dependent. The role of other TLRs in regulating the response to H. pylori was not addressed in those studies, however. Importantly, those studies did demonstrate that both wild type and an isogenic CagA-deficient strain induced IL-8 production to the same extent, however, strains deleted in the entire cag pathogenicity island could not induce IL-8 production. Thus, when viewed in light of the data presented herein, which demonstrates a requirement for TLR expression to induce responses to H. pylori, the presence of an intact type IV secretion system is a necessary, but not sufficient, requirement for the induction of epithelial cell responses to H. pylori infection.


    FOOTNOTES
 
* This work was supported by National Institutes of Health Grants RO1-AI34358 (to M. F. S.), RO1-AI41548 and RO1-AI51291 (to J. B. G.), T32 DK07769 (to A. M. F.), and T32 GM08136 (to A. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

To whom correspondence should be addressed: University of Virginia Health System, P.O. Box 800708, Charlottesville, VA 22908-0708. Tel.: 434-924-2573; Fax: 434-243-9645; E-mail: mfs3k{at}virginia.edu.

1 The abbreviations used are: IL-8, interleukin-8; TLR, Toll-like receptor; LPS, lipopolysaccharide; RT, reverse transcriptase; FBS, fetal bovine serum; CHO, Chinese hamster ovary. Back



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Meyer-ter-Vehn, T., Covacci, A., Kist, M., and Pahl, H. L. (2000) J. Biol. Chem. 275, 16064–16072[Abstract/Free Full Text]
  2. Keates, S., Hitti, Y. S., Upton, M., and Kelly, C. P. (1997) Gastroenterology 113, 1099–1109[CrossRef][Medline] [Order article via Infotrieve]
  3. Maeda, S., Akanuma, M., Mitsuno, Y., Hirata, Y., Ogura, K., Yoshida, H., Shiratori, Y., and Omata, M. (2001) J. Biol. Chem. 276, 44856–44864[Abstract/Free Full Text]
  4. Aihara, M., Tsuchimoto, D., Takizawa, H., Azuma, A., Wakebe, H., Ohmoto, Y., Imagawa, K., Kikuchi, M., Mukaida, N., and Matsushima, K. (1997) Infect. Immun. 65, 3218–3224[Abstract]
  5. Crowe, S. E., Alvarez, L., Dytoc, M., Hunt, R. H., Muller, M., Sherman, P., Patel, J., Jin, Y., and Ernst, P. B. (1995) Gastroenterology 108, 65–74[CrossRef][Medline] [Order article via Infotrieve]
  6. Maeda, S., Yoshida, H., Ogura, K., Mitsuno, Y., Hirata, Y., Yamaji, Y., Akanuma, M., Shiratori, Y., and Omata, M. (2000) Gastroenterology 119, 97–108[CrossRef][Medline] [Order article via Infotrieve]
  7. Medzhitov, R., and Janeway, C., Jr. (2000) Trends Microbiol. 8, 452–456[CrossRef][Medline] [Order article via Infotrieve]
  8. Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., and Akira, S. (1999) Immunity 11, 443–451[CrossRef][Medline] [Order article via Infotrieve]
  9. Underhill, D. M., Ozinsky, A., Smith, K. D., and Aderem, A. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 14459–14463[Abstract/Free Full Text]
  10. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., and Beutler, B. (1998) Science 282, 2085–2088[Abstract/Free Full Text]
  11. Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., and Aderem, A. (2001) Nature 410, 1099–1103[CrossRef][Medline] [Order article via Infotrieve]
  12. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., and Akira, S. (2000) Nature 408, 740–745[CrossRef][Medline] [Order article via Infotrieve]
  13. Vasselon, T., and Detmers, P. A. (2002) Infect. Immun. 70, 1033–1041[Free Full Text]
  14. Martin, M. U., and Wesche, H. (2002) Biochim. Biophys. Acta 1592, 265–280[Medline] [Order article via Infotrieve]
  15. Backhed, F., Rokbi, B., Torstensson, E., Zhao, Y., Nilsson, C., Seguin, D., Normark, S., Buchan, A. M., and Richter-Dahlfors, A. (2003) J. Infect. Dis. 187, 829–836[CrossRef][Medline] [Order article via Infotrieve]
  16. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., and Akira, S. (1999) J. Immunol. 162, 3749–3752[Abstract/Free Full Text]
  17. Kawahara, T., Teshima, S., Oka, A., Sugiyama, T., Kishi, K., and Rokutan, K. (2001) Infect. Immun. 69, 4382–4389[Abstract/Free Full Text]
  18. Hirschfeld, M., Ma, Y., Weis, J. H., Vogel, S. N., and Weis, J. J. (2000) J. Immun. 165, 618–622[Abstract/Free Full Text]
  19. Carl, V. S., Brown-Steinke, K., Nicklin, M. J., and Smith, M. F., Jr. (2002) J. Biol. Chem. 277, 17448–17456[Abstract/Free Full Text]
  20. Moran, A. P., Lindner, B., and Walsh, E. J. (1997) J. Bacteriol. 179, 6453–6463[Abstract/Free Full Text]
  21. Hirschfeld, M., Weis, J. J., Toshchakov, V. V., Salkowski, C. A., Cody, M. J., Ward, D. C., Qureshi, N., Michalek, S. M., and Vogel, S. N. (2001) Infect. Immun. 69, 1477–1482[Abstract/Free Full Text]
  22. Kawahara, T., Kuwano, Y., Teshima-Kondo, S., Kawai, T., Nikawa, T., Kishi, K., and Rokutan, K. (2001) J. Med. Invest. 48, 190–197[Medline] [Order article via Infotrieve]
  23. Sakagami, T., Vella, J., Dixon, M. F., O'Rourke, J., Radcliff, F., Sutton, P., Shimoyama, T., Beagley, K., and Lee, A. (1997) Infect. Immun. 65, 3310–3316[Abstract]
  24. Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B., and Miller, S. I. (2002) Nat. Immunol. 3, 354–359[CrossRef][Medline] [Order article via Infotrieve]
  25. Read, M. A., Cordle, S. R., Veach, R. A., Carlisle, C. D., and Hawiger, J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9887–9891[Abstract/Free Full Text]
  26. Delude, R. L., Savedra, R., Jr., Zhao, H. L., Thieringer, R., Yamamoto, S., Fenton, M. J., and Golenbock, D. T. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9288–9292[Abstract/Free Full Text]
  27. Hirschfeld, M., Kirschning, C. J., Schwandner, R., Wesche, H., Weis, J. H., Wooten, R. M., and Weis, J. J. (1999) J. Immunol. 163, 2382–2386[Abstract/Free Full Text]
  28. Eaton, K. A., Suerbaum, S., Josenhans, C., and Krakowka, S. (1996) Infect. Immun. 64, 2445–2448[Abstract]
  29. Ottemann, K. M., and Lowenthal, A. C. (2002) Infect. Immun. 70, 1984–1990[Abstract/Free Full Text]
  30. Ohta-Tada, U., Takagi, A., Koga, Y., Kamiya, S., and Miwa, T. (1997) Scand. J. Gastroenterol. 32, 455–459[Medline] [Order article via Infotrieve]
  31. Cunningham, M. D., Seachord, C., Ratcliffe, K., Bainbridge, B., Aruffo, A., and Darveau, R. P. (1996) Infect. Immun. 64, 3601–3608[Abstract]
  32. Toshchakov, V., Jones, B. W., Perera, P. Y., Thomas, K., Cody, M. J., Zhang, S., Williams, B. R., Major, J., Hamilton, T. A., Fenton, M. J., and Vogel, S. N. (2002) Nat. Immunol. 3, 392–398[CrossRef][Medline] [Order article via Infotrieve]
  33. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S. (1999) Immunity 11, 115–122[CrossRef][Medline] [Order article via Infotrieve]
  34. Guillemin, K., Salama, N. R., Tompkins, L. S., and Falkow, S. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 15136–15141[Abstract/Free Full Text]
  35. Higashi, H., Tsutsumi, R., Muto, S., Sugiyama, T., Azuma, T., Asaka, M., and Hatakeyama, M. (2002) Science 295, 683–686[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
H. Wu, H. Wang, W. Xiong, S. Chen, H. Tang, and D. Han
Expression Patterns and Functions of Toll-Like Receptors in Mouse Sertoli Cells
Endocrinology, September 1, 2008; 149(9): 4402 - 4412.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. Zorko and R. Jerala
Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics
J. Antimicrob. Chemother., July 16, 2008; (2008) dkn270v1.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
Diya Zhang, Lili Chen, Shenglai Li, Zhiyuan Gu, and Jie Yan
Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1{beta}, TNF-{alpha} and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS
Innate Immunity, April 1, 2008; 14(2): 99 - 107.
[Abstract] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Mita, M. Satoh, A. Shimada, M. Okajima, S. Azuma, J. S. Suzuki, K. Sakabe, S. Hara, and S. Himeno
Metallothionein is a crucial protective factor against Helicobacter pylori-induced gastric erosive lesions in a mouse model
Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G877 - G884.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
P. Adam, B. Schmausser, M. Gobeler-Kolve, H. K. Muller-Hermelink, and M. Eck
Gastric extranodal marginal zone B-cell lymphomas of MALT type exclusively express toll-like receptor 4 in contrast to other lymphomas infiltrating the stomach
Ann. Onc., March 1, 2008; 19(3): 566 - 569.
[Abstract] [Full Text] [PDF]